Research discovers possible link between Crohn's and Parkinson's in Jewish population

January 11, 2018, The Mount Sinai Hospital
Protein structure of LRRK2, which has been identified as a common risk factor for both Crohn’s and Parkinson’s disease. Credit: Jill K Gregory, MFA, CMI, Associate Director of Instructional Technology & Roberto Sanchez, Ph.D., Director, Structure-Based Drug Discovery Core,Icahn School of Medicine at Mount Sinai

Mount Sinai Researchers have just discovered that patients in the Ashkenazi Jewish population with Crohn's disease (a chronic inflammatory of the digestive system) are more likely to carry the LRRK2 gene mutation. This gene is the major genetic cause of Parkinson's disease, which is a movement disorder. The study's findings, published in the January 10, 2018 issue of Science Translational Medicine, and featured on the cover, could help doctors better understand Crohn's disease, determine specifically who's at risk, and develop new drugs for treatment and/or prevention by targeting this specific gene.

"Crohn's is a complex disorder with multiple and environmental factors involved, which disproportionally affects individuals of Ashkenazi Jewish ancestry," explained lead researcher Inga Peter, Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai in New York City. "The presence of shared LRRK2 mutations in patients with Crohn's disease and Parkinson's disease provides refined insight into disease mechanisms and may have major implications for the treatment of these two seemingly unrelated diseases."

Dr. Peter and a team of Mount Sinai Investigators used international data from the last decade up to the present to analyze the occurrence of 230,000 coding genetic mutations in the human genome of 2,066 patients with Crohn's disease and compared them to 3,633 people without the disorder. All were of Ashkenazi Jewish descent. They identified mutations in the LRRK2 gene that are more frequently found in Crohn's disease cases as compared to unaffected individuals. When they discovered a link between Crohn's and the LRRK2 gene mutations they went further to assess the possible genetic link between Crohn's and Parkinson's. The team then looked at a much larger sample of 24,570 people including patients with Crohn's, Parkinson's, and no disease at all (each group consisted of Jewish and non-Jewish subjects).

Gene network map illustrating newly identified connections between Crohn's disease and Parkinson's disease. Credit: K.Y. Hui et al., Science Translational Medicine (2018)

The study found two mutations of the LRRK2 gene in Crohn's disease patients. One of them (called the risk mutation) was more common in patients with Crohn's, while the other (the protective mutation) was more prevalent in patients without the disease. Most Crohn's disease patients who carried the risk mutation developed the disease on average six years earlier than those who did not carry this mutation. The research also shows that more Crohn's with the risk mutation developed the disease in the small intestine, compared to those without the mutation. If the disease starts in the small intestine, it becomes more difficult to manage and often leads to complications and surgeries. It's important to note that the effect of these mutations was observed in Ashkenazi Jewish populations and non-Jewish populations.

"Defining the biology of naturally occurring protective is quite important, because they define desired outcomes for potentially new therapies," explained the study's co-author Judy H. Cho, MD, Director of the Sanford Grossman Center for Integrative Studies in Crohn's disease, and the Charles F. Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai.

"Identifying associated with disease risk is an effective way to better understand disease mechanisms, identify individuals at risk, and develop novel drug targets to treat the disease," Dr. Peter added. "Our research may also help identify individuals who would benefit the most of LRRK2-directed therapies, thereby contributing to the field of personalized medicine."

Explore further: Researchers find 5 risk biomarkers for Crohn's disease in Jews of Eastern European descent

More information: Ken Y. Hui et al. Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease, Science Translational Medicine (2018). DOI: 10.1126/scitranslmed.aai7795

Related Stories

Researchers find 5 risk biomarkers for Crohn's disease in Jews of Eastern European descent

March 8, 2012
In the largest study of its kind, researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn's disease in Jews of Eastern European descent, also known as Ashkenazi Jews. ...

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

New blood signature analysis may help diagnose Parkinson's disease earlier

April 6, 2015
A new blood test may more accurately identify blood signatures, or biomarkers, for Parkinson's disease (PD), according to a new study published in the journal Movement Disorders. The study, conducted by researchers at Mount ...

Review examines rates and predictors of recurrence following surgery for Crohn's disease

December 8, 2016
Some patients with Crohn's disease, a chronic inflammatory disease that affects the lining of the digestive tract, require surgery to remove part or all of the large intestine; however, surgery does not cure the condition ...

Liquid nutrition may benefit children with Crohn's disease

August 23, 2017
An analysis of published studies indicates that exclusive enteral nutrition (EEN)—when individuals receive only liquid nutrition—may be an effective treatment for children with Crohn's disease. The findings are published ...

A Crohn's disease-associated gene expression profile and microbial community

July 8, 2014
Crohn's and other inflammatory bowel diseases (IBDs) can be painful and debilitating. There are no known cures for these diseases, but the symptoms can be managed. It is widely thought that IBDs develop as a result of an ...

Recommended for you

Scientists manipulate 'satellite cells' to speed healing

April 24, 2018
Muscle aches and pains, whether from stretching, strenuous exercise or just normal wear and tear, can put a crimp in your day, a limp in your step and be an actual pain in the neck. But no matter the severity, stem cells ...

Advanced sensor to unlock the secrets of the brain

April 24, 2018
Researchers have announced the development of a state-of-the-art sensor that can for the first time detect signalling molecules, called cytokines, which operate in the living brain. Cytokines in the brain are secreted by ...

New cell therapy aids heart recovery—without implanting cells

April 23, 2018
Heart disease is a major global health problem—myocardial infarction annually affects more than one million people in the U.S. alone, and there is still no effective treatment. The adult human heart cannot regenerate itself ...

DOR protein deficiency favors the development of obesity

April 20, 2018
Obesity is a world health problem. Excessive accumulation of fat tissue (adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer. However, some obese individuals are less ...

Stem-cell technology aids 3-D printed cartilage repair

April 20, 2018
Novel stem-cell technology developed at Swinburne will be used to grow the massive number of stem cells required for a new hand-held 3-D printer that will enable surgeons to create patient-specific bone and cartilage.

Researchers identify blood biomarkers that may help diagnose, confirm concussions

April 20, 2018
Researchers from the University of California, Irvine, Georgetown University and the University of Rochester have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.